Home208340 • KOSDAQ
add
PharmAbcine Inc
Previous close
₩2,915.00
Year range
₩2,520.00 - ₩3,970.00
Market cap
76.32B KRW
P/E ratio
-
Dividend yield
-
Primary exchange
KOSDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (KRW) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 637.99M | 9,898.20% |
Operating expense | 2.47B | -25.88% |
Net income | -1.70B | 56.23% |
Net profit margin | -266.48 | 99.56% |
Earnings per share | — | — |
EBITDA | -2.17B | 29.70% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (KRW) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 44.54B | 170.96% |
Total assets | 53.21B | 112.07% |
Total liabilities | 8.38B | -32.42% |
Total equity | 44.83B | — |
Shares outstanding | 80.19M | — |
Price to book | 5.21 | — |
Return on assets | -15.34% | — |
Return on capital | -17.11% | — |
Cash Flow
Net change in cash
| (KRW) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -1.70B | 56.23% |
Cash from operations | -1.97B | 45.57% |
Cash from investing | -30.02B | -10,863.46% |
Cash from financing | 30.08B | 1,567.20% |
Net change in cash | -951.22M | 85.21% |
Free cash flow | 683.84M | 123.09% |
About
CEO
Founded
2008
Website
Employees
35
